HCV infection should be managed in specialist centres

Gut

Volumn 51, Issue 5, 2002, Pages 626-627

  Brown, J L ^a  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEMOGRAPHY; FOLLOW UP; GENOTYPE; HEALTH CARE MANAGEMENT; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ABUSE; NONHUMAN; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SCORING SYSTEM; SHORT SURVEY; TREATMENT PLANNING; UNITED KINGDOM; VIRUS TYPING;

GASTROENTEROLOGY; HEPACIVIRUS; HEPATITIS C, CHRONIC; HOSPITALS, DISTRICT; HOSPITALS, GENERAL; HUMANS; PATIENT CARE MANAGEMENT; PRACTICE GUIDELINES;

EID: 0036838567     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.51.5.626     Document Type: Short Survey

References (12)

1. Guidance on the use of ribavirin and interferon alpha for hepatitis C. NICE technology appraisal guidance, No 14; Oct 2000.
2. National Statistics-The UK in figures-Population and Migration. http://www.statistics.gov.uk.
3. Alter M, Margolis H, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-905.
4. Management of hepatitis C. NIH Consensus Statement Online 1997;15:1-41 .
5. EASL International Consensus Conference on Hepatitis C. J Hepatol 1999;31(suppl 1):3-8.
6. Booth J, O'Grady J, Neuberger J. Clinical guidelines on the management of hepatitis C. Gut 2001;49(suppl 1)11-21 (http://gut.bmjjournals.com/).
7. British Liver Trust. http://www.british-liver-trust.org.uk.
8. Poynard T, Marcellin P, Lee S, et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C. International Hepatitis Interventional Therapy Group. Lancet 1998;352:1426-32.
9. McHutchison J, Gordon S, Schiff E, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998;339:1485-92.
10. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
11. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289-93.
12. Dusheiko G, Khakoo S, Soni P, et al. Fortnightly review: A rational approach to the management of hepatitis C infection. BMJ 1996;312:357-64.